{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:54:19Z","timestamp":1785578059608,"version":"3.56.0"},"reference-count":110,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Therapeutic genome editing technology has been widely used as a powerful tool for directly correcting genetic mutations in target pathological tissues and cells to cure of diseases. The modification of specific genomic sequences can be achieved by utilizing programmable nucleases, such as Meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat-associated nuclease Cas9 (CRISPR\/Cas9). However, given the properties, such as large size, negative charge, low membrane penetrating ability, as well as weak tolerance for serum, and low endosomal escape, of these nucleases genome editing cannot be successfully applied unless in vivo delivery of related programmable nucleases into target organisms or cells is achieved. Here, we look back at delivery strategies having been used in the in vivo delivery of three main genome editing nucleases, followed by methodologies currently undergoing testing in clinical trials, and potential delivery strategies provided by analyzing characteristics of nucleases and commonly used vectors.<\/jats:p>","DOI":"10.3390\/ijms17050626","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T12:22:05Z","timestamp":1461759725000},"page":"626","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["In Vivo Delivery Systems for Therapeutic Genome Editing"],"prefix":"10.3390","volume":"17","author":[{"given":"Luyao","family":"Wang","sequence":"first","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Li","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dang","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"He","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defang","family":"Li","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohao","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuegong","family":"Xu","sequence":"additional","affiliation":[{"name":"Central Laboratory, Zheng Zhou Hospital of Traditional Chinese Medicine, Zhengzhou 450000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-7695","authenticated-orcid":false,"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone &amp; Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 00852, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: Prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cbpa.2012.06.007","article-title":"Advances in targeted genome editing","volume":"16","author":"Ousterout","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_6","first-page":"1363","article-title":"Gene Therapy Progress and Prospects: Electroporation and other Physical Methods","volume":"11","author":"Wells","year":"2004","journal-title":"Nat. Rev."},{"key":"ref_7","first-page":"346","article-title":"Progress and problems with the use of viral vectors for gene therapy. Nature reviews","volume":"4","author":"Thomas","year":"2003","journal-title":"Genetics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jconrel.2011.11.021","article-title":"Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery","volume":"161","author":"Vader","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_10","first-page":"1","article-title":"Viral vectors: A look back and ahead on gene transfer technology","volume":"36","author":"Vannucci","year":"2013","journal-title":"New Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.gt.3302364","article-title":"Immune responses to gene therapy vectors: Influence on vector function and effector mechanisms","volume":"11","author":"Bessis","year":"2004","journal-title":"Gene Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","article-title":"Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors","volume":"17","author":"Baum","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"ref_13","unstructured":"Vectors Used in Gene Therapy Clinical Trials. Available online: http:\/\/www.wiley.com\/\/legacy\/wileychi\/genmed\/clinical."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15217","DOI":"10.1021\/jacs.5b09602","article-title":"Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery","volume":"137","author":"Sun","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2014.12.036","article-title":"Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN","volume":"205","author":"Chung","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1126\/science.1079512","article-title":"Enhancing Gene Targeting with Designed Zinc Finger Nucleases","volume":"300","author":"Bibikova","year":"2003","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zhang, S., Huang, X., Orwig, K.E., and Sheng, Y. (2013). Rapid assembly of customized TALENs into multiple delivery systems. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080281"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1093\/nar\/20.21.5625","article-title":"Nested chromosomal fragmentation in yeast using the meganuclease I-Sce I: A new method for physical mapping of eukaryotic genomes","volume":"20","author":"Thierry","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/nar\/29.18.3757","article-title":"Homing endonucleases: Structural and functional insight into the catalysts of intron\/intein mobility","volume":"29","author":"Chevalier","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1093\/nar\/gkl720","article-title":"A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences","volume":"34","author":"Smith","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1517\/14712590903213669","article-title":"Targeted approaches for gene therapy and the emergence of engineered meganucleases","volume":"9","author":"Galetto","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1093\/nar\/gni175","article-title":"In vivo selection of engineered homing endonucleases using double-strand break induced homologous recombination","volume":"33","author":"Chames","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/gt.2010.26","article-title":"Meganucleases can restore the reading frame of a mutated dystrophin","volume":"17","author":"Chapdelaine","year":"2010","journal-title":"Gene Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jgm.879","article-title":"Efficient in toto targeted recombination inmouse liver by meganuclease-induced double-strand break","volume":"8","author":"Gouble","year":"2006","journal-title":"J. Gene Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1093\/nar\/gkr524","article-title":"Efficient gene targeting mediated by a lentiviral vector-associated meganuclease","volume":"39","author":"Izmiryan","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3686","article-title":"A guide to genome engineering with programmable nucleases","volume":"15","author":"Kim","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T Lymphocyte-Directed Gene Therapy for ADASCID: Initial Trial Results after 4 Years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2012.04.008","article-title":"Virus-mediated gene delivery for human gene therapy","volume":"161","author":"Giacca","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/1747-0862.1000096","article-title":"Progress and Problems with Viral Vectors for Delivery of TALENs","volume":"8","author":"Bergmann","year":"2014","journal-title":"J. Mol. Genet. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652307780859062","article-title":"Current Advances and Future Challenges in Adenoviral Vector Biology and Targeting","volume":"7","author":"Campos","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/COH.0b013e32834122d7","article-title":"Chemokine receptor 5 knockout strategies","volume":"6","author":"Cannon","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biotechadv.2012.10.001","article-title":"Development of hybrid viral vectors for gene therapy","volume":"31","author":"Huang","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and Problems with the Use of Viral Vectors for Gene Therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2009.319","article-title":"Recent advances in lentiviral vector development and applications","volume":"18","author":"Matrai","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/sj.mt.6300281","article-title":"Stable gene transfer to muscle using non-integrating lentiviral vectors","volume":"15","author":"Apolonia","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/hum.2009.167","article-title":"Fate of Recombinant Adeno-Associated Viral Vector Genomes during DNA Double-Strand Break-Induced Gene Targeting in Human Cells","volume":"21","author":"Gellhaus","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_41","first-page":"35","article-title":"Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs","volume":"20","author":"Ellis","year":"2013","journal-title":"Nat. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","article-title":"Robust ZFN-mediated genome editing in adult hemophilic mice","volume":"122","author":"Anguela","year":"2013","journal-title":"Blood J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/hum.2011.140","article-title":"Versatile and Efficient Genome Editing in Human Cells by Combining Zinc-Finger Nucleases with Adeno-Associated Viral Vectors","volume":"23","author":"Gellhaus","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/hum.2012.168","article-title":"The Nontoxic Cell Cycle Modulator Indirubin Augments Transduction of Adeno-Associated Viral Vectors and Zinc-Finger Nuclease-Mediated Gene Targeting","volume":"24","author":"Rahman","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/nar\/gkq826","article-title":"Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template","volume":"39","author":"Michael","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Hojun, L., Harigot, V., Doyon, Y., Li, J., Bhagwat, A., Wong, S., Anguela, X., Sharma, R., Ivanciu, L., and Murphy, S.M. (2010, January 10\u201313). LBA-5 Phenotypic Correction of a Mouse Model of Hemophilia B by in vivo Genetic Correction of F9 Gene. Proceedings of the American Society of Hematology Annual Meeting, San Diego, CA, USA.","DOI":"10.1182\/blood.V116.21.LBA-5.LBA-5"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Philip","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0003-9861(02)00725-7","article-title":"Cationic liposome-mediated gene delivery: Biophysical study and mechanism of internalization","volume":"410","author":"Almofti","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases","volume":"26","author":"Perez","year":"2008","journal-title":"Nat. Biothechnol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/bit.22749","article-title":"Reilly, Enhancement of DNA Uptake in FUT8-Deleted CHO Cells for Transient Production of Afucosylated Antibodies","volume":"106","author":"Wong","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nmeth.2030","article-title":"Targeted gene knockout by direct delivery of zinc-finger nuclease proteins","volume":"9","author":"Gaj","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ramakrishna, S., Kim, Y.H., and Kim, H. (2013). Stability of Zinc Finger Nuclease Protein Is Enhanced by the Proteasome Inhibitor MG132. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054282"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s00018-015-1956-5","article-title":"Recent developments and clinical studies utilizing engineered zinc finger nuclease technology","volume":"72","author":"Jo","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1093\/nar\/gkr597","article-title":"A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity","volume":"39","author":"Mussolino","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1093\/nar\/gkt721","article-title":"Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre\/LoxP cassette exchange in human-induced pluripotent stem cells","volume":"41","author":"Zhu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/156652321402140318165450","article-title":"Targeted Genome Editing Tools for Disease Modeling and Gene Therapy","volume":"14","author":"Cai","year":"2014","journal-title":"Curr. Gene Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/nar\/gkr976","article-title":"Nonspaced inverted DNA repeats are preferential targets for homology-directed gene repair in mammalian cells","volume":"40","author":"Holkers","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1093\/nar\/gks1446","article-title":"Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells","volume":"41","author":"Holkers","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1172\/JCI78206","article-title":"TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy","volume":"125","author":"Hu","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2045-9769-2-5","article-title":"Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs","volume":"2","author":"Ru","year":"2013","journal-title":"Cell Regen."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Liu, J., Gaj, T., Patterson, J.T., Sirk, S.J., and Barbas, C.F. (2014). Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085755"},{"key":"ref_65","first-page":"331","article-title":"RNA-guided genetic silencing systems in bacteria and archaea","volume":"482","author":"Wiedenheft","year":"2012","journal-title":"Nat. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.virol.2012.10.003","article-title":"Memory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information","volume":"434","author":"Peter","year":"2012","journal-title":"Virology"},{"key":"ref_67","first-page":"23","article-title":"CRISPR Provides Acquired Resistance against Viruses in Prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.1179555","article-title":"CRISPR\/Cas, the Immune System of Bacteria and Archaea","volume":"327","author":"Horvath","year":"2010","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/nar\/30.2.482","article-title":"A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis","volume":"30","author":"Makarova","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn.2015.2","article-title":"Applications of CRISPR-Cas system in neuroscience","volume":"17","author":"Heidenreich","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","article-title":"In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9","volume":"33","author":"Swiech","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1153","article-title":"Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors","volume":"23","author":"Lai","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fnmol.2014.00076","article-title":"Biology of adeno-associated viral vectors in the central nervous system","volume":"7","author":"Murlidharan","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/biot.201400046","article-title":"CRISPR\/Cas9-mediated genome engineering: An adeno-associated viral (AAV) vector toolbox","volume":"9","author":"Senis","year":"2014","journal-title":"Biotechnol. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymeth.2015.08.012","article-title":"Optimization of a multiplex CRISPR\/Cas system for use as an antiviral therapeutic","volume":"91","author":"Kennedy","year":"2015","journal-title":"Methods"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/j.febslet.2014.09.008","article-title":"Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR\/Cas9","volume":"588","author":"Cheng","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jgm.187","article-title":"Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo","volume":"3","author":"Wightman","year":"2011","journal-title":"J. Gene Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/ncomms8391","article-title":"Somatic CRISPR\/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling","volume":"6","author":"Zuckermann","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/hum.2015.069","article-title":"Challenges in CRISPR\/CAS9 Delivery: Potential Roles of Nonviral Vectors","volume":"26","author":"Li","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"ref_85","first-page":"571","article-title":"A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG\u2013PEI-cholesterol lipopolymer in the treatment of persistent of recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A gynecologic oncology group study","volume":"3","author":"Alvarez","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.171264.113","article-title":"Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA","volume":"24","author":"Ramakrishna","year":"2014","journal-title":"Genome Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature13695","article-title":"Saturation editing of genomic regions by multiplex homology-directed repair","volume":"513","author":"Findlay","year":"2014","journal-title":"Nature"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated directmutation of cancer genes in themouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"ref_91","first-page":"234","article-title":"CRISPR\/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods","volume":"1856","author":"Jo","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1469-0691.12449","article-title":"Cytomegalovirus vaccine: Phase II clinical trial results","volume":"20","author":"Rieder","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nmeth0210-91a","article-title":"Genome editing with modularly assembled zinc-finger nucleases","volume":"7","author":"Kim","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nbt.2517","article-title":"A library of TAL effector nucleases spanning the human genome","volume":"31","author":"Kim","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.mt.6300357","article-title":"DNA-binding Specificity Is a Major Determinant of the Activity and Toxicity of Zinc-finger Nucleases","volume":"16","author":"Cornu","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep05105","article-title":"Adenoviral vector delivery of RNA-guided CRISPR\/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells","volume":"4","author":"Maggio","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/ncomms7952","article-title":"Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium","volume":"6","author":"McNeer","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nnano.2008.34","article-title":"Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications","volume":"3","author":"Tasciotti","year":"2008","journal-title":"Nat. Nanotechnol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.colsurfb.2010.05.026","article-title":"Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery","volume":"79","author":"Liu","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jconrel.2013.10.015","article-title":"Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts","volume":"172","author":"He","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Francisco Mart\u00edn, K.B., Cobo, M., Mu\u00f1oz, P., Anderson, P., and Toscano, M.G. (2011). New Vectors for Stable and Safe Gene Modification. Gene Therapy\u2014Developments and Future Perspectives, InTech.","DOI":"10.5772\/10622"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth0111-7b","article-title":"Live-cell dSTORM with SNAP-tag fusion proteins","volume":"8","author":"Klein","year":"2011","journal-title":"Nat. Methods"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1101\/gr.089417.108","article-title":"Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly","volume":"19","author":"Kim","year":"2009","journal-title":"Genome Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nmeth.2364","article-title":"TALENs and ZFNs are associated with different mutation signatures","volume":"10","author":"Kim","year":"2013","journal-title":"Nat. Methods"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.coi.2012.08.013","article-title":"Creating genetic resistance to HIV","volume":"24","author":"Burnett","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood.V126.23.2046.2046","article-title":"First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL","volume":"126","author":"Qasim","year":"2015","journal-title":"Blood"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/5\/626\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:22:58Z","timestamp":1760210578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/5\/626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":110,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"alternative-id":["ijms17050626"],"URL":"https:\/\/doi.org\/10.3390\/ijms17050626","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}